Rob earned his Ph.D. in biomedical engineering at the Georgia Institute of Technology and Emory University in 2018. Rob suffers from beta-thalassemia major, a genetic blood disorder that causes him to be severely anemic and requires that he receive regular blood transfusions. His experience living with this disease motivates him to develop diagnostic technologies for anemia that can improve quality of life. Rob has extensive experience in computational analysis and leads to the development of our non-invasive technologies.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)